Targaprimir-96 TFA

Targaprimir-96 TFA is a potent, selective small molecule inhibitor that binds pri-miR-96 with low nanomolar affinity to block its processing. It specifically reduces mature miR-96 levels in breast cancer cells, inducing apoptosis, while showing no activity in normal breast cells. This compound is a valuable tool for studying oncogenic miRNA function in vitro and exploring miRNA-targeted cancer therapies.